Greenwich Lifesciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $3 | $0 | $0 |
Gross Profit | ||||
EBITDA | -4,045 | -3,281 | -2,728 | |
EBIT | -4,045 | -3,282 | -8,084 | -2,729 |
Net Income | -4,025 | -3,258 | -8,040 | -2,668 |
Net Change In Cash | 0 | 3 | 0 | 0 |
Free Cash Flow | -2,233 | -1,834 | -1,852 | -2,583 |
Cash | 3,125 | 2,749 | 4,091 | 5,822 |
Basic Shares | 13,370 | 13,171 | 13,152 | 13,142 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3 | -3 | -3 | -3 |
EBITDA | -15,785 | -9,324 | -8,036 | -4,594 |
EBIT | -15,788 | -9,327 | -8,040 | -4,597 |
Net Income | -15,788 | -8,891 | -7,825 | -4,570 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -1,456 | |||
Free Cash Flow | -7,266 | -6,478 | -6,200 | -4,291 |
Cash | 4,091 | 6,989 | 13,468 | 27,204 |
Basic Shares | 13,014 | 12,848 | 12,913 | 12,944 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.30 |
2025-03-31 | -$0.25 |
2024-12-31 | -$0.61 |
